ANTIVIRICOS-BICTEGRAVIR+EMTRICITABINA + TENOFOVIR ALAFENAMIDA - 3MESES
Buyer: Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
- Published
- 8 September 2026
- Estimated value
- €370,412
- Place of performance
- PT300
- Procedure
- Restricted procedure
- Lots
- 1
- Notice number
- 00616442-2026
- Reference
- 6855cfca-f243-4bdf-95d7-146315b885df
- Official source
- Official source
CPV codes
- 33690000Medicamentos diversos
Description
ANTIVIRICOS-BICTEGRAVIR+EMTRICITABINA + TENOFOVIR ALAFENAMIDA - 3MESES
Award criteria
- Price — 100%
Awards
| Awarded to | Amount | Date |
|---|---|---|
| GILEAD SCIENCES,LDA | €370,412 | — |
Official publications
- TED · 00616442-2026 · 8 September 2026
- OJS · 173/2026 · 8 September 2026
Other tenders from Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
- IMUNOGLOBULINAS E SOROS - 3 MESES
- INIBIDORES DE TIROSINACINASES - OSIMERTINIB - 3 MESES
- ANTIASMATICOS - MEPOLIZUMAB - 3 MESES
- CARDIOVERSORES DESFIBRILHADORES
- VACINAS - VACINA CONTRA O PAPILOMAVIRUS HUMANO (NONAVALENTE)
- IMUNOMODULADORES - PEMBROLIZUMAB - 2 MESES
- MEDICAMENTO P/SISTEMA NERVOSO CENTRAL (OUTROS) - TAFAMIDIS - 3 MESES
- IMUNOMODULADORES - DUPILUMAB - 3 MESES
- IMUNOMODULADORES - DARATUMUMAB - 3 MESES
- ANTIVIRICOS - 3 MESES
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is €370,412.
- Who is the buyer of this tender?
- The contracting authority is Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.